Neat
8-Aminoguanosine; 3868-32-4; Guanosine, 8-amino-; SHO2CA1BRO; NSC-90390; RefChem:106906; CHEMBL2021376; 180288-69-1; 2, 8-DIAMINO-9-[(2R, 3R, 4S, 5R)-3, 4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1H-PURIN-6-ONE; C10H14N6O5; MFCD00036759; 2, 8-Diamino-9-((2R, 3R, 4S, 5R)-3, 4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1, 9-dihydro-6H-purin-6-one; 2, 8-Diaminoinosine; NSC 90390; Trastuzumab (anti-HER2); INOSINE, 2, 8-DIAMINO-; 2, 8-diamino-9-[(2R, 3R, 4S, 5R)-3 and 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one; 8-Amino-D-guanosine; Adenosine Impurity 67; UNII-SHO2CA1BRO
2, 8-diamino-9-[(2R, 3R, 4S, 5R)-3 and 4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
InChI=1S/C10H14N6O5/c11-9-14-6-3(7(20)15-9)13-10(12)16(6)8-5(19)4(18)2(1-17)21-8/h2,4-5,8,17-19H,1H2,(H2,12,13)(H3,11,14,15,20)/t2-,4-,5-,8-/m1/s1